Akers Biosciences announced its collaboration with Premas Biotech has successfully completed the milestone of obtaining clones of all three coronavirus antigens, Spike (S), Envelope (E), and Membrane (M) that they have selected for their vaccine candidate. Read more...
Cytovia Therapeutics is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis. Read more...
Luminex announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its ARIES® SARS-CoV-2 Assay for rapid detection of the virus that causes COVID-19. Read more...
Kedrion Biopharma has started the development of a plasma-derived therapy for treating the COVID-19 virus that could make it available to patients in as little as three to six months. Read more...